Analysis: Suven Pharmaceuticals Limited

NSE:SUVENPHAR Market cap: ₹41.2K cr
RS rating: 45 Stage: Stage 1

Get valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for Suven Pharmaceuticals Limited and 4,900+ companies.

Sign in
5-day free pass. No card required.